Video Author: Neil Osterweil Publish date: December 2, 2018
SAN DIEGO – Median overall survival among patients with complete responses to CAR-T cell therapy in the JULIET trial has not been reached.
Video Author: Neil Osterweil Publish date: December 2, 2018
SAN DIEGO – Gut microbiome diversity predicts overall survival after hematopoietic cell transplant.
News Author: Neil Osterweil Publish date: December 2, 2018
SAN DIEGO – Median overall survival for patients with complete responses to CAR T-cell therapy was not reached through 19 months of follow-up.
News Author: Neil Osterweil Publish date: December 1, 2018
SAN DIEGO – Survival outcomes were nearly identical and adverse events were lower with four versus six cycles of R-CHOP in patients with favorable-...
Video Author: Neil Osterweil Publish date: December 1, 2018
SAN DIEGO – Progression-free, event-free, and overall survival were comparable with that of patients assigned to six cycles of therapy.
News Author: Neil Osterweil Publish date: December 1, 2018
SAN DIEGO – Genetically modified autologous stem cells increased protective fetal hemoglobin and decreased sickle hemoglobin in an adult with sickl...
Video Author: Neil Osterweil Publish date: December 1, 2018
SAN DIEGO – One adult with sickle cell disease had near-complete remission of symptoms after 6 months of follow-up.
News Author: Neil Osterweil Publish date: November 28, 2018
Cortactin, a cytoskeleton-remodeling adapter protein, is expressed on most CLL cells, but not similar-appearing MCL cells.
News Author: Neil Osterweil Publish date: November 21, 2018
Big trials, big results in malignant and nonmalignant hematologic disorders are on the program at the 2018 ASH annual meeting.
News Author: Neil Osterweil Publish date: November 19, 2018
Discordant gene expression results between primary tumors and metastases reveal a need for prognostic biomarkers in metastases.
News Author: Neil Osterweil Publish date: November 19, 2018
Patients with sporadic clear cell renal cell carcinomas expressing PD-L1 had worse disease-free survival.
News Author: Neil Osterweil Publish date: November 16, 2018
Long-term data suggest R-CHOP can be effective as first-line treatment for patients with follicular lymphoma (FL). In a phase 2-3 trial, investigat...
News Author: Neil Osterweil Publish date: November 15, 2018
Long-term follow-up of a randomized trial showed durable efficacy of R-CHOP with no increase in histological transformation or secondary cancers.
News Author: Neil Osterweil Publish date: November 15, 2018
BOSTON—Results of a pilot program suggest preoperative management of anemia can reduce transfusion rates and cut costs, but the effect on patient outc...
News Author: Neil Osterweil Publish date: November 14, 2018
BOSTON – Managing anemia prior to cardiac surgery saved a hospital more than $100,000 in transfusion costs in a pilot program.
